Who owns BIODEXA PHARMACEUTICALS PLC?
- Ticker: BDRX
- CUSIP Number: 59564r708
Tip: Access positions for across all investors
Analyze quarterly positions in Biodexa Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Biodexa Pharmaceuticals stock
Who bought or sold BIODEXA PHARMACEUTICALS PLC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Virtu Financial | 36k | $32k | 100% | Jun 2024 |
|
| Citadel Advisors | 33k | $30k | 100% | Jun 2024 |
|
| Susquehanna International | 30k | $27k | 100% | Jun 2024 |
|
| Two Sigma Securities | 21k | $18k | 100% | Jun 2024 |
|
| Ground Swell Capital | 13k | $12k | 100% | Jun 2024 |
|
| GAMMA Investing | 3.9k | $3.5k | -65% | Jun 2024 |
|
| Rhumbline Advisers | 2.7k | $2.4k | 444% | Jun 2024 |
|
| UBS Group | 2.4k | $4.0k | 306% | Mar 2024 |
|
| Contravisory Investment Management | 1.0k | $896.000000 | 100% | Jun 2024 |
|
| Bank of America Corporation | 859.00 | $768.976800 | -84% | Jun 2024 |
|
| Morgan Stanley | 16.00 | $14.000000 | 0% | Jun 2024 |
|
| Headlands Technologies | 8.00 | $7.000000 | 100% | Jun 2024 |
|